Patents by Inventor Jerry Kaplan

Jerry Kaplan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Identification of the hepcidin binding site on ferroportin
    Patent number: 8530619
    Abstract: The invention relates to materials and procedures for the use of the hepcidin binding domain (HBD) on ferroportin. A 20 amino acid peptide of the HBD was synthesized and shown to recapitulate the characteristics and specificity of hepcidin binding to cell surface ferroportin. The affinity of hepcidin for the HBD peptide permits a rapid, sensitive assay of hepcidin in biological fluids.
    Type: Grant
    Filed: October 27, 2008
    Date of Patent: September 10, 2013
    Assignee: University of Utah Research Foundation
    Inventors: Jerry Kaplan, Diane M. Ward, Ivana De Domenico
  • IDENTIFICATION OF THE HEPCIDIN BINDING SITE ON FERROPORTIN
    Publication number: 20100292147
    Abstract: The invention relates to materials and procedures for the use of the hepcidin binding domain (HBD) on ferroportin. A 20 amino acid peptide of the HBD was synthesized and shown to recapitulate the characteristics and specificity of hepcidin binding to cell surface ferroportin. The affinity of hepcidin for the HBD peptide permits a rapid, sensitive assay of hepcidin in biological fluids.
    Type: Application
    Filed: October 27, 2008
    Publication date: November 18, 2010
    Inventors: Jerry Kaplan, Diane M. Ward, Ivana De Domenico
  • Compositions for the diagnosis and treatment of chediak-higashi syndrome
    Publication number: 20020115144
    Abstract: The present invention relates to the identification of novel nucleic acid molecules and proteins encoded by such nucleic acid molecules or degenerate variants thereof, that participate in the differentiation and/or function of intracellular vesicles. The nucleic acid molecules of the present invention represent the genes corresponding to the mammalian bg gene, a gene that, when mutated, is responsible for the human Chediak-Higashi syndrome.
    Type: Application
    Filed: August 10, 2001
    Publication date: August 22, 2002
    Applicant: Millennium
    Inventors: Jerry Kaplan, Charles M. Perou, Karen J. Moore
  • Compositions for the diagnosis and treatment of Chediak-Higashi syndrome
    Patent number: 6310182
    Abstract: The present invention relates to the identification of novel nucleic acid molecules and proteins encoded by such nucleic acid molecules or degenerate variants thereof, that participate in the differentiation and/or function of intracellular vesicles. The nucleic acid molecules of the present invention represent the genes corresponding to the mammalian bg gene, a gene that, when mutated, is responsible or the human Chediak-Higashi syndrome.
    Type: Grant
    Filed: September 14, 1999
    Date of Patent: October 30, 2001
    Assignees: Millennium Pharmaceuticals, Inc., The University of Utah Research Foundation
    Inventors: Jerry Kaplan, Charles M. Perou, Karen J. Moore
  • Compositions for the diagnosis and treatment of Chediak-Higashi syndrome
    Patent number: 5952223
    Abstract: The present invention relates to the identification of novel nucleic acid molecules and proteins encoded by such nucleic acid molecules or degenerate variants thereof, that participate in the differentiation and/or function of intracellular vesicles. The nucleic acid molecules of the present invention represent the genes corresponding to the mammalian bg gene, a gene that, when mutated, is responsible for the human Chediak-Higashi syndrome.
    Type: Grant
    Filed: March 21, 1997
    Date of Patent: September 14, 1999
    Assignees: Millennium Pharmaceuticals, The University of Utah Research Foundation
    Inventors: Jerry Kaplan, Charles M. Perou, Karen J. Moore